Stem cell therapeutics (ExCellThera)

N/A

Report date: 2026/04/08 15:41:59

Base Information

Drug NameStem cell therapeutics (ExCellThera)
Drug Alias NameECT-003ECT-005UM171 + UM092UM171 + UM390ECT-002
ClassificationCell and gene therapy > Cell therapy > Stem cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionStem cells stimulantsHematopoietic progenitor cell antigen CD34 agonists
TargetsHematopoietic progenitor cell antigen CD34
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesExcellthera Inc
China Registration ClassN/A

Develop Information

Active CompaniesExcellthera Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A